Cargando…

Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease

This paper was aimed to explore the application of the block matching pyramid (BMP) algorithm in echocardiographic spot tracking in patients with coronary heart disease (CHD) and angina pectoris, as well as the effect of Shexiang Baoxin pills (a kind of drug containing musk, which is good for cardia...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Junqing, Wang, Xu, Li, Lingyan, Zhang, Hong, He, Ruiqing, Han, Bingyu, Liu, Zongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363440/
https://www.ncbi.nlm.nih.gov/pubmed/34394889
http://dx.doi.org/10.1155/2021/3819900
_version_ 1783738353339858944
author Gao, Junqing
Wang, Xu
Li, Lingyan
Zhang, Hong
He, Ruiqing
Han, Bingyu
Liu, Zongjun
author_facet Gao, Junqing
Wang, Xu
Li, Lingyan
Zhang, Hong
He, Ruiqing
Han, Bingyu
Liu, Zongjun
author_sort Gao, Junqing
collection PubMed
description This paper was aimed to explore the application of the block matching pyramid (BMP) algorithm in echocardiographic spot tracking in patients with coronary heart disease (CHD) and angina pectoris, as well as the effect of Shexiang Baoxin pills (a kind of drug containing musk, which is good for cardiac diseases) on blood lipids, cardiac function, and curative effect. 206 patients with CHD angina pectoris in the hospital from July 2018 to May 2020 were selected as the research subjects and were enrolled into the control (Ctrl) group (conventional treatment, n = 103) and the observation group (the Shexiang Baoxin pill was given on the basis of conventional treatment, n = 103) in random. Then, the patients' echocardiograms were obtained, and the BMP algorithm was used to track the echocardiograms. At 12 months after treatment, the total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were compared. Besides, the differences between left ventricular end-systolic volume (LVESV), left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic volume (LVEDV), left ventricular end-diastolic dimension (LVEDD), cardiac index (CI), cardiac output (CO), and LVEF were observed. Finally, the efficacy of angina pectoris and electrocardiogram was calculated. It was found that the BMP algorithm can track the echocardiograms and display the movement and displacement of the patients' left ventricle. After treatment, in contrast with the Ctrl, the levels of TC, TG, and LDL-C in the observation group were obviously lower (P < 0.05); the LVESV, LVEDV, and LVEF were obviously lower (P < 0.05), the LVESD, LVEDD, CO, and CI were obviously higher (P < 0.05), the total score of angina after treatment was obviously lower (P < 0.05), and the total effective rates of angina pectoris and echocardiogram were obviously higher (P < 0.05). In conclusion, echocardiographic spot tracking can realize the diagnosis of patients with CHD angina pectoris, and Shexiang Baoxin pill can regulate the blood lipid level and improve the echocardiographic indicators and the clinical efficacy is obvious.
format Online
Article
Text
id pubmed-8363440
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-83634402021-08-14 Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease Gao, Junqing Wang, Xu Li, Lingyan Zhang, Hong He, Ruiqing Han, Bingyu Liu, Zongjun J Healthc Eng Research Article This paper was aimed to explore the application of the block matching pyramid (BMP) algorithm in echocardiographic spot tracking in patients with coronary heart disease (CHD) and angina pectoris, as well as the effect of Shexiang Baoxin pills (a kind of drug containing musk, which is good for cardiac diseases) on blood lipids, cardiac function, and curative effect. 206 patients with CHD angina pectoris in the hospital from July 2018 to May 2020 were selected as the research subjects and were enrolled into the control (Ctrl) group (conventional treatment, n = 103) and the observation group (the Shexiang Baoxin pill was given on the basis of conventional treatment, n = 103) in random. Then, the patients' echocardiograms were obtained, and the BMP algorithm was used to track the echocardiograms. At 12 months after treatment, the total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) were compared. Besides, the differences between left ventricular end-systolic volume (LVESV), left ventricular end-systolic diameter (LVESD), left ventricular end-diastolic volume (LVEDV), left ventricular end-diastolic dimension (LVEDD), cardiac index (CI), cardiac output (CO), and LVEF were observed. Finally, the efficacy of angina pectoris and electrocardiogram was calculated. It was found that the BMP algorithm can track the echocardiograms and display the movement and displacement of the patients' left ventricle. After treatment, in contrast with the Ctrl, the levels of TC, TG, and LDL-C in the observation group were obviously lower (P < 0.05); the LVESV, LVEDV, and LVEF were obviously lower (P < 0.05), the LVESD, LVEDD, CO, and CI were obviously higher (P < 0.05), the total score of angina after treatment was obviously lower (P < 0.05), and the total effective rates of angina pectoris and echocardiogram were obviously higher (P < 0.05). In conclusion, echocardiographic spot tracking can realize the diagnosis of patients with CHD angina pectoris, and Shexiang Baoxin pill can regulate the blood lipid level and improve the echocardiographic indicators and the clinical efficacy is obvious. Hindawi 2021-08-06 /pmc/articles/PMC8363440/ /pubmed/34394889 http://dx.doi.org/10.1155/2021/3819900 Text en Copyright © 2021 Junqing Gao et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gao, Junqing
Wang, Xu
Li, Lingyan
Zhang, Hong
He, Ruiqing
Han, Bingyu
Liu, Zongjun
Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease
title Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease
title_full Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease
title_fullStr Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease
title_full_unstemmed Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease
title_short Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease
title_sort block matching pyramid algorithm-based analysis on efficacy of shexiang baoxin pills guided by echocardiogram (ecg) on patients with angina pectoris in coronary heart disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363440/
https://www.ncbi.nlm.nih.gov/pubmed/34394889
http://dx.doi.org/10.1155/2021/3819900
work_keys_str_mv AT gaojunqing blockmatchingpyramidalgorithmbasedanalysisonefficacyofshexiangbaoxinpillsguidedbyechocardiogramecgonpatientswithanginapectorisincoronaryheartdisease
AT wangxu blockmatchingpyramidalgorithmbasedanalysisonefficacyofshexiangbaoxinpillsguidedbyechocardiogramecgonpatientswithanginapectorisincoronaryheartdisease
AT lilingyan blockmatchingpyramidalgorithmbasedanalysisonefficacyofshexiangbaoxinpillsguidedbyechocardiogramecgonpatientswithanginapectorisincoronaryheartdisease
AT zhanghong blockmatchingpyramidalgorithmbasedanalysisonefficacyofshexiangbaoxinpillsguidedbyechocardiogramecgonpatientswithanginapectorisincoronaryheartdisease
AT heruiqing blockmatchingpyramidalgorithmbasedanalysisonefficacyofshexiangbaoxinpillsguidedbyechocardiogramecgonpatientswithanginapectorisincoronaryheartdisease
AT hanbingyu blockmatchingpyramidalgorithmbasedanalysisonefficacyofshexiangbaoxinpillsguidedbyechocardiogramecgonpatientswithanginapectorisincoronaryheartdisease
AT liuzongjun blockmatchingpyramidalgorithmbasedanalysisonefficacyofshexiangbaoxinpillsguidedbyechocardiogramecgonpatientswithanginapectorisincoronaryheartdisease